The proposed bill, General Assembly Proposed Bill No. 6097, aims to enhance transparency regarding prescription drug discounts provided under Section 340B of the Public Health Service Act. It mandates that pharmacy benefit managers, pharmacies, insurers, and hospitals that dispense or provide coverage for these discounted drugs must file a report with the Office of Health Strategy. This report will detail the costs charged to consumers for any discounted prescription drugs, ensuring that consumers are aware of the actual prices they are paying.

The purpose of this legislation is to protect consumers from overpaying for prescription drugs and to prevent premature enrollment in Medicaid due to income deductions related to drug costs. By requiring these entities to disclose pricing information, the bill seeks to promote fairness and transparency in the pharmaceutical market, ultimately benefiting consumers who rely on these discounts.